Vascular Resistance: Clinical Trials

2 trials for Vascular Resistance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Terminated 1

Follow Vascular Resistance: new trials by email Literature Review of Vascular Resistance trials Research Report on Vascular Resistance

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Resveratrol and Cardiovascular Health in the Elderly
Resveratrol, Placebo - Vascular Resistance, Hypertension
Phase 1 / Phase 2TerminatedNational Institute on Aging (NIA)732015-07-142022-12-23
Endothelin-Receptor Blockade in Coronary Heart Disease
BQ-123 and BQ-788 - Coronary Vessels, Endothelins
Phase 1CompletedMedical University of Vienna262003-05-012007-01-26

Narrower conditions

Coronary Disease (1)  ·  Hypertension (1)  ·  Inflammation (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

BQ 788 (1)  ·  Resveratrol (1)  ·  cyclo(Trp-Asp-Pro-Val-Leu) (1)

Sponsors

Medical University of Vienna (1)  ·  National Institute on Aging (NIA) (1)

Countries

Austria (1)  ·  United States (1)

Top investigators

Ajoy C Karikkineth, M.D. (1)  ·  Thomas Neunteufl, MD (1)

Results publications

PMID 19414437